Documente Academic
Documente Profesional
Documente Cultură
Matthew Andry, J y, MD
IU Health Bloomington MDWeightWoRx BeWell Grant Grant-Centerstone Centerstone
1. 2. 3 3. 4.
We have the SAME genetics as those whose genes were selected for in a calorie poor environment. It believes there will be a famine tomorrow No Weight Set Point. The heavier the better Energy Savings Account
Not about Anti Anti-Aging Aging Not about Body Building Its It s about: HOMEOSTASIS Not about maximizing hormone levels Its It s about balancing hormone levels and rere approximating normal/optimal function in disordered body y systems y Too much can be just as bad as not enough
$$$
TIME!!
CALORIES IN
Social
Metabolic
(Hormones)
y Psych
Metabolic/Hormonal Influences
Calories Out
10% DIGESTION
70%
20% PHYSICAL ACTIVITY
CALORIES OUT
Obesity y is a result of energy gy imbalance. Loss of Homeostasis. Hormones are substances released from specific ifi places l i in the h b body d to cause specific ifi effects in different tissues Hormones are the currency currency of homeostasis Innumerable hormones involved with weight management. g Improper hormone balance can be a major cause of weight gain and hinder weight loss. P bl Problems arise i f from too much h and d too li little. l
1 in 3 Americans have insulin resistance Require high levels of insulin to control g glucose. This causes a reflexive hypoglycemia and leads to overeating, g especially p y of carbohydrates y
Glucose
Insulin
Hypoglycemia Hyperphagia/carbohydrate yp p g y cravings g Cortisol release Increased Fat Storage (incr. lipoprotein lipase) Fatigue Disrupts other hormone systems
Delayed rise in glucose due to prolonged digestion Gives insulin more time to work at lower levels Pushes glucose into cells Increased muscle mass improves Insulin Sensitivity Metformin, Januvia, Vytorin, Byetta
Exercise
Medications
Biguanide. g Used for over 50 y years Can treat AND prevent Diabetes
Mechanism: Drives glucose into cells and inhibits glucagon conversion on glycogen to glucose in the liver. liver Have to have healthy kidneys Watch Liver Enzymes closely (NASH???) Treatment of choice in Insulin Resistance Syndromes y
They increase GLP-1 Activity GLP-1: an incretin: released from the gut after f di food intake t k t to assist i t appropriate i t i insulin li release, inhibits glucagon, and SLOWS GASTRIC EMPTYING. Low risk for hypoglycemia Safe, , but subtle and expensive! p
Byetta ( (lizard lizard spit), spit ), Vytorin These are ANALOGUES of GLP-1. Stronger More effective Stronger, effective, Studied for weight loss, Expensive SQ Injections Can cause lots of Nausea and vomitting if client overeats Low risk for hypoglycemia
Energy/Glucose Utilization, Body Temperature, Catecholamine sensitivity, Heart Rate, Fat utilization, Growth, Memory and Concentration
Produces T4 (which the body converts to T3) Production d controlled ll d by b the h pituitary gland l d and its release of Thyroid Stimulating Hormone (TSH)
Low Thyroid y can be a major j barrier to weight g loss. Low Thyroid Symptoms:
Cold Intolerance, Low BBT Goiter (from TSH overstimulation) Weight Gain Menorrhagia Edema Brain Fog Heart arrythmias D Depression i
Assessed by y levels of TSH ( (longer g half-life than T4 and T3) Problem: What is a normal TSH?? Major debate in Endocrinology currently Normal values 0.34 mIU/L N / to 5.6 mIU/L / What is an Optimal TSH?
Treat with:
Iodine Supplementation Synthetic y T4 ( (Synthroid) y ) Synthetic T3 (Cytomel) Natural Thyroid (Armour) Compounded Formulations (specific ratios, individualized per patient)
Menopause and Perimenopause Imbalances in E and P are common during this p period. Estrogen Dominance very common
New Name? Insulin Related Sex Hormone Dysfunction Extremely y common 4-12% of the p population. p (much higher for sub-acute forms) Leading hormonal cause of infertility High insulin increases GnRH pulse frequency, raising LH, lowering FSH. Leads to high androgens and low SHBG
Waldstreicher et al. 1988, , Morales et al. 1996 MacArthur et al. 1958, Yen et al. 1970
Clinical Features:
Weight Gain Anovulation Acne Hirsutism Insulin Resistance/Hyperinsulinemia Edema I Irregular/painful l / i f l periods i d Infertility Ovarian Cysts
Inability to lose weight PMS-type symptoms Headaches Edema Anxiety/Depression Insomnia Nausea/Bloating
Estrogen and Progesterone levels fall as approach menopause. Often P falls farther faster than E. ( (Especially p y if excess adipose tissue, which produces E) Occurs despite p monthly y cycling. y g
Is it safe? Womens Health Initiative Recent Reversal At least safe, at best, effective for breast cancer prevention
( (Think PMS) ) Headaches (migraine) Fluid Retention Breast Tenderness Weight Gain (hips) F ti Fatigue Anxiety Insomnia Dysmenorrhea Decreased Libido
( (More Serious Risks) ) Endometrial/Breast Hyper plasia O i C Ovarian Cysts Insulin Resistance Fibroids Endometriosis Fibrocystic y Breasts Infertility Blood Clots
Weight Loss High g Fiber Diet Reduce insulin resistance Avoid extrinsic Estrogens: soy, chemicals, pesticides
Males lose about 3% Free T p per y year after 40.1 Functions pertaining to weight:
Increase lean mass, decrease body fat Increases insulin sensitivity Deficiencies lead to fat accumulation, insulin resistance and diabetes Can increase appetite Debate on what are normal levels
HRT. Is it safe? WHI: 2002. Stopped early due to 0.3%/yr risk increase in breast cancer for women taking g Premarin and Provera. Millions of women told to stop p hormones Instructed smallest dose for shortest time Results were extrapolated p to all hormones Why??? Not evidence based to do so.
HRT is it safe?
Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy
Andrea Z. LaCroix, PhD; Rowan T. Chlebowski, MD, PhD; JoAnn E. Manson, MD, DrPH; Aaron K. Aragaki, MS; Karen C.
J Johnson,MD,MPH; , , ; Lisa Martin, , MD; ; Karen L. Margolis, g , MD, , MPH; ; Marcia L. Stefanick, , PhD; Robert Brzyski, MD, PhD; J. David Curb, MD, MPH; Barbara V. Howard, PhD; Cora E. Lewis, MD, MSPH; Jean Wactawski-Wende, PhD for the WHI Investigators
HRT is it safe?
Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy
Johnson,MD,MPH; J , , ; Lisa Martin, , MD; ; Karen L. Margolis, g , MD, , MPH; ; Marcia L. Stefanick, , PhD; ; Robert Brzyski, MD, PhD; J. David Curb, MD, MPH; Barbara V. Howard, PhD; Cora E. Lewis, MD, MSPH; Jean Wactawski-Wende, PhD for the WHI Investigators
Andrea Z. LaCroix, PhD; Rowan T. Chlebowski, MD, PhD; JoAnn E. Manson, MD, DrPH; Aaron K. Aragaki, MS; Karen C.
Topical versus Injectable Multiple New Agents Again too much not great either Again, Risks: irritability, erythrocytosis, elevated cholesterol, hair loss, BPH No evidence it causes Prostate Cancer. Some that it decreases it. Can make an active cancer grow faster Will raise E2 levels as well, close monitoring g
In y younger g males ( <45-50), ), can use agents g to increase endogenous Testosterone production Cl id/A i d Clomid/Arimadex
Functions like LH in the male Increases T production, partial estrogen reducer Tends e ds to cause weight e g t loss oss ( (hypothalamic ypot a a c moa??) oa??)
Cycloset y .
New medication for diabetes. Increases DA activity in the hypothalamus Moves glucose into cells Improves pp glucose w/o increasing insulin! Seems to increase glucose utilization Helps with dysmetabolism and dysglycemia, may be particularly helpful in circadian misalignment (night shift workers).